{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-050830","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.388560+00:00","generated_at":"2026-05-29T01:48:28.410459+00:00","sec_items":["1.01","5.02","2.01","3.02","3.03","5.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Mangoceuticals acquires mushroom patent for 515k shares; CEO Cohen secures 75.5% voting control of subsidiary M&P","bullets":["Acquired mushroom patent WO 2023/086647 from Greenfield Investments for 515,000 restricted shares of common stock.","Contributed substantially all assets (MangoRx Mexico and UK) to new subsidiary Mango & Peaches Corp.","CEO Jacob Cohen received 1.7M common shares (25.4%) and Series A preferred with 51% voting power, totaling 75.5% voting control of M&P.","CEO base salary raised to $360k/year; severance increased to 3x salary plus target bonus; term extended to Dec 2027.","Granted Greenfield a co-exclusive license to patents for 10% royalty on gross sales starting Dec 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-050830","json":"https://secwatch.observer/filing/0001493152-24-050830.json","markdown":"https://secwatch.observer/filing/0001493152-24-050830.md","text":"https://secwatch.observer/filing/0001493152-24-050830.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224050830/0001493152-24-050830-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224050830/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:48:28.410459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}